A detailed history of Fmr LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Fmr LLC holds 2,321,504 shares of EXEL stock, worth $62.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,321,504
Previous 1,962,417 18.3%
Holding current value
$62.2 Million
Previous $46.6 Million 12.02%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$20.34 - $23.73 $7.3 Million - $8.52 Million
359,087 Added 18.3%
2,321,504 $52.2 Million
Q1 2024

May 13, 2024

SELL
$20.17 - $23.93 $22.4 Million - $26.6 Million
-1,109,602 Reduced 36.12%
1,962,417 $46.6 Million
Q4 2023

Feb 13, 2024

BUY
$19.25 - $24.13 $3.61 Million - $4.53 Million
187,595 Added 6.5%
3,072,019 $73.7 Million
Q3 2023

Nov 13, 2023

BUY
$19.04 - $22.74 $4.7 Million - $5.61 Million
246,605 Added 9.35%
2,884,424 $63 Million
Q2 2023

Aug 11, 2023

SELL
$18.17 - $20.48 $60.6 Million - $68.3 Million
-3,334,080 Reduced 55.83%
2,637,819 $50.4 Million
Q1 2023

May 11, 2023

SELL
$16.3 - $19.41 $115 Million - $137 Million
-7,078,279 Reduced 54.24%
5,971,899 $116 Million
Q4 2022

Feb 13, 2023

SELL
$14.96 - $17.39 $37.8 Million - $44 Million
-2,527,392 Reduced 16.22%
13,050,178 $209 Million
Q3 2022

Nov 10, 2022

SELL
$15.68 - $22.27 $28.5 Million - $40.5 Million
-1,819,716 Reduced 10.46%
15,577,570 $244 Million
Q2 2022

Aug 12, 2022

BUY
$17.44 - $23.16 $3.44 Million - $4.57 Million
197,254 Added 1.15%
17,397,286 $362 Million
Q1 2022

May 13, 2022

SELL
$17.03 - $22.67 $27.3 Million - $36.4 Million
-1,604,948 Reduced 8.53%
17,200,032 $390 Million
Q4 2021

Feb 14, 2022

SELL
$15.84 - $21.88 $134,671 - $186,023
-8,502 Reduced 0.05%
18,804,980 $344 Million
Q3 2021

Nov 15, 2021

SELL
$16.3 - $21.14 $21 Million - $27.2 Million
-1,288,106 Reduced 6.41%
18,813,482 $398 Million
Q2 2021

Aug 13, 2021

BUY
$17.95 - $25.56 $361 Million - $514 Million
20,101,588 New
20,101,588 $366 Million

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $8.63B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.